Arca
Skip to content
Tools
Tools

Dario Blood Glucose Monitoring System

Recall Z-0260-2020, part of FDA recall event 83761. See LabStyle Innovations's company page.

LABSTYLE INNOVATIONS started this Class II device recall on Aug 29, 2019 (voluntary: firm initiated); FDA lists it as terminated, terminated May 5, 2020.

  • Classification: Class II
  • Started: Aug 29, 2019
  • Status: Terminated

Why It Was Recalled

Class II

The Dario-Blood Glucose Tracker Android App versions 4.3.0-4.3.2 may experience duplicate logging of a blood glucose level reading.

Record

Product
Dario Blood Glucose Monitoring System, Model No. 1015-05, running Android software versions 4.3.0-4.3.2
Quantity
126,271 (83,141 US; 43,130 OUS)
Lots and codes
Android App Software versions 4.3.0-4.3.2
Distribution
Nationwide domestic distribution. Foreign distribution to Australia, Canada, UK, and Italy.
Recalling firm
LABSTYLE INNOVATIONS, Ramat Gan, Israel
How the firm notified
Other
FDA classified
Oct 31, 2019

FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.